Your browser doesn't support javascript.
loading
Research progress in the diagnosis and treatment of intrahepatic cholangiocellular carcinoma / 介入放射学杂志
Article in Zh | WPRIM | ID: wpr-694254
Responsible library: WPRO
ABSTRACT
Intrahepatic cholangiocellular carcinoma (ICC) is a primary tumor originating from the epithelial cells of bile duct. In recent years, incidence of ICC in the world is on the rise, and it has become the second common malignant tumors of the liver, with its incidence being next only to hepatocellular carcinoma (HCC). The onset of ICC is insidious, its clinical manifestations are lack of specificity, most of the patients are already in the advanced stage when the diagnosis is confirmed, thus, affecting the treatment and prognosis. Therefore, early diagnosis and treatment is essential. The radical treatment plan is mainly surgical excision, and other treatment options include systemic chemotherapy, local ablation, transcatheter arterial chemoembolization (TACE), selective intraarterial radiotherapy with yttrium-90 microspheres (SIRT-90Y), 125I seed implantation, etc. This article aims to make a comprehensive introduction about the recent advances in the diagnosis and treatment of ICC. (J Intervent Radiol, 2018, 27:285-289)
Key words
Full text: 1 Index: WPRIM Type of study: Diagnostic_studies / Screening_studies Language: Zh Journal: Journal of Interventional Radiology Year: 2018 Type: Article
Full text: 1 Index: WPRIM Type of study: Diagnostic_studies / Screening_studies Language: Zh Journal: Journal of Interventional Radiology Year: 2018 Type: Article